Revita DMR granted FDA Breakthrough Device Designation for T2DM
Fractyl Laboratories has announced that the FDA has granted Breakthrough Device Designation for Revita DMR (duodenal mucosal resurfacing)...
Revita DMR granted FDA Breakthrough Device Designation for T2DM
Lexington’s AEON Endostapler reaches 10,000 procedure milestone
First patient enrolled in pivotal REVITA-T2Di study for T2DM
ReShape is More Than Just ‘The Lap-Band company’
FDA grants Breakthrough Device Designation for Apollo’s Orbera Balloon for NASH treatment
GORE launches GORE Synecor Intraperitoneal Biomaterial in Europe, the Middle East And South Africa
TransEnterix gains CE Mark for machine vision system in robotic surgery